BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Regulatory actions for August 28, 2024

Aug. 28, 2024
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neuros Medical, Vitestro.
Read More

Other news to note for August 28, 2024

Aug. 28, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biolab, Cerevasc, Glytec, Jedmed, Life Molecular Imaging, Mellingmedical, Roche, Siemens.
Read More
Hair follicle containing phagocytic stem cells
Dermatologic

Stem cells eat dead cells to ensure tissue integrity

Aug. 28, 2024
By Mar de Miguel
Phagocytosis – eliminating millions of dead cells every day – requires specialized cells such as macrophages, the true professionals, which migrate to engulf waste and dying cells.
Read More
Diabetes glucose monitor

Abbott scores $54M win in glucose test strip diversion case

Aug. 27, 2024
By Mark McCarty
A magistrate judge for a U.S. district court has recommend that Abbott Laboratories receive $54 million in damages for third-party diversion of glucose test strips into the U.S. from other nations.
Read More

Regulatory actions for August 27, 2024

Aug. 27, 2024
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accuray, Aesculap, Boston Scientific, Clearmind, Illumina, Insulet.
Read More

In the clinic for August 27, 2024

Aug. 27, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aethlon, Skincure Oncology.
Read More

Other news to note for August 27, 2024

Aug. 27, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atricure, Contipi, Eversana, Medtronic, Neuraxis, Pacemate, Sonovascular, Spectral AI.
Read More

Appointments and advancements for August 27, 2024

Aug. 27, 2024
New hires and promotions in the med-tech industry, including: Bioaesthetics, Brightflow, Glucotrack, RQM+.
Read More

Financings for August 27, 2024

Aug. 27, 2024
Med-tech firms raising money in public or private financings, including: Apiject Systems, Harvard Apparatus Regenerative Technology, Work Medical Technology Group.
Read More
Seegene Novaplex MPXV OPXV Assay

Asia med-tech stocks rise as WHO moves to contain mpox outbreak

Aug. 27, 2024
By Marian (YoonJee) Chu
Shares of Chinese and South Korean med-tech companies continued to rise after the World Health Organization declared mpox a public health emergency of international concern Aug. 14 after recent outbreaks.
Read More
Previous 1 2 … 352 353 354 355 356 357 358 359 360 … 10245 10246 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 4, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Xray showing lung cancer on tablet

    How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III

    BioWorld
    Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing